Cingulate Earnings Estimates, EPS & Revenue | NASDAQ:CING

Comments

Cingulate Inc Earnings Estimates

CINGNASDAQ

Trade with Public

$5.21

-0.14-2.71%

Last update: Apr 15, 12:07 PM

Overview NewsEarningsAnalyst Ratings Insider Trades Short Interest Stock Report

Cingulate Earnings Estimates, EPS & Revenue | NASDAQ:CING

Cingulate (CING) is scheduled to report Q1 earnings on May 7, 2026. Analysts estimate EPS of $-0.56 and quarterly revenue of N/A.

In the most recent quarter (Q4), Cingulate reported EPS of $-0.84, beating estimates of $-1.15 by 0.27%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Over the last 4 quarters, Cingulate has averaged an EPS surprise of 0.36% and a revenue surprise of 0.00%.

Earnings Date

May 7

EPS Estimate

$-0.560

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–

Cingulate Earnings History

Analyze the earnings history of Cingulate using advanced sorting and filters.

Loading calendar...

Cingulate (CING) Earnings Per Share

The chart below shows Cingulate's reported EPS compared to analyst estimates over recent quarters.

Cingulate (CING) Revenue

The chart below shows Cingulate's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is Cingulate (NASDAQ:CING) reporting earnings?

Cingulate (CING) is scheduled to report earnings on May 7, 2026. The last reported earnings were for reported on March 18, 2026 for Q4.

What were the latest earnings per share (EPS) for Cingulate (NASDAQ:CING)?

The Actual EPS was $-0.84, which beat the estimate of $-1.15.

What were Cingulate’s (NASDAQ:CING) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

People Also Watch

Cumberland Pharmaceuticals Inc

Rani Therapeutics Holdings Inc

NASDAQ:RANI

$0.91

9.27%

Incannex Healthcare Inc

Telomir Pharmaceuticals Inc

Impact BioMedical Inc

AMEX:IBO

$0.64

-3.37%

Cingulate Earnings Estimates, EPS & Revenue | NASDAQ:CING

Cingulate (CING) is scheduled to report Q1 earnings on May 7, 2026. Analysts estimate EPS of $-0.56 and quarterly revenue of N/A.

In the most recent quarter (Q4), Cingulate reported EPS of $-0.84, beating estimates of $-1.15 by 0.27%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

Over the last 4 quarters, Cingulate has averaged an EPS surprise of 0.36% and a revenue surprise of 0.00%.

Earnings Date

May 7

EPS Estimate

$-0.560

Quarterly Revenue Estimate

–

Annual Revenue
(as of Dec 31)

–